• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Wellbeing Digital Sciences Inc.

    Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Announces Cease Trade Order
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Provides Bi-Weekly Default Status Report
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Digital to Participate in The Global Biomedical Design Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Provides Bi-Weekly Default Status Report
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Digital to Participate in MarigoldLIVE: International Women’s Day Networking Event
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Provides Bi-Weekly Default Status Report
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Digital Announces Change of Auditor
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary Mindscape Treats its 1,000th Patient
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Digital Announces Resignation of Directors
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF OTC
    Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Digital Subsidiary KGK to Participate in Microdose Wonderland Miami Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Wellbeing Announces Definitive Agreement to Divest IRP Health
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Tickers KONEF
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.